| pubmed-article:8702446 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:8702446 | lifeskim:mentions | umls-concept:C0003873 | lld:lifeskim |
| pubmed-article:8702446 | lifeskim:mentions | umls-concept:C0011923 | lld:lifeskim |
| pubmed-article:8702446 | lifeskim:mentions | umls-concept:C0115305 | lld:lifeskim |
| pubmed-article:8702446 | lifeskim:mentions | umls-concept:C0014257 | lld:lifeskim |
| pubmed-article:8702446 | lifeskim:mentions | umls-concept:C0392292 | lld:lifeskim |
| pubmed-article:8702446 | lifeskim:mentions | umls-concept:C1524063 | lld:lifeskim |
| pubmed-article:8702446 | lifeskim:mentions | umls-concept:C1879547 | lld:lifeskim |
| pubmed-article:8702446 | pubmed:issue | 8 | lld:pubmed |
| pubmed-article:8702446 | pubmed:dateCreated | 1996-9-5 | lld:pubmed |
| pubmed-article:8702446 | pubmed:abstractText | To determine the potential of 111In-labeled anti-E-selectin monoclonal antibody (MAb) to image localized endothelial activation in rheumatoid arthritis (RA). | lld:pubmed |
| pubmed-article:8702446 | pubmed:language | eng | lld:pubmed |
| pubmed-article:8702446 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8702446 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:8702446 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8702446 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8702446 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8702446 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8702446 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8702446 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:8702446 | pubmed:month | Aug | lld:pubmed |
| pubmed-article:8702446 | pubmed:issn | 0004-3591 | lld:pubmed |
| pubmed-article:8702446 | pubmed:author | pubmed-author:PetersA MAM | lld:pubmed |
| pubmed-article:8702446 | pubmed:author | pubmed-author:HaskardD ODO | lld:pubmed |
| pubmed-article:8702446 | pubmed:author | pubmed-author:ChapmanP TPT | lld:pubmed |
| pubmed-article:8702446 | pubmed:author | pubmed-author:JamarFF | lld:pubmed |
| pubmed-article:8702446 | pubmed:author | pubmed-author:KeelanE TET | lld:pubmed |
| pubmed-article:8702446 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:8702446 | pubmed:volume | 39 | lld:pubmed |
| pubmed-article:8702446 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:8702446 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:8702446 | pubmed:pagination | 1371-5 | lld:pubmed |
| pubmed-article:8702446 | pubmed:dateRevised | 2010-3-24 | lld:pubmed |
| pubmed-article:8702446 | pubmed:meshHeading | pubmed-meshheading:8702446-... | lld:pubmed |
| pubmed-article:8702446 | pubmed:meshHeading | pubmed-meshheading:8702446-... | lld:pubmed |
| pubmed-article:8702446 | pubmed:meshHeading | pubmed-meshheading:8702446-... | lld:pubmed |
| pubmed-article:8702446 | pubmed:meshHeading | pubmed-meshheading:8702446-... | lld:pubmed |
| pubmed-article:8702446 | pubmed:meshHeading | pubmed-meshheading:8702446-... | lld:pubmed |
| pubmed-article:8702446 | pubmed:meshHeading | pubmed-meshheading:8702446-... | lld:pubmed |
| pubmed-article:8702446 | pubmed:meshHeading | pubmed-meshheading:8702446-... | lld:pubmed |
| pubmed-article:8702446 | pubmed:meshHeading | pubmed-meshheading:8702446-... | lld:pubmed |
| pubmed-article:8702446 | pubmed:meshHeading | pubmed-meshheading:8702446-... | lld:pubmed |
| pubmed-article:8702446 | pubmed:meshHeading | pubmed-meshheading:8702446-... | lld:pubmed |
| pubmed-article:8702446 | pubmed:meshHeading | pubmed-meshheading:8702446-... | lld:pubmed |
| pubmed-article:8702446 | pubmed:meshHeading | pubmed-meshheading:8702446-... | lld:pubmed |
| pubmed-article:8702446 | pubmed:meshHeading | pubmed-meshheading:8702446-... | lld:pubmed |
| pubmed-article:8702446 | pubmed:year | 1996 | lld:pubmed |
| pubmed-article:8702446 | pubmed:articleTitle | Use of a radiolabeled monoclonal antibody against E-selectin for imaging of endothelial activation in rheumatoid arthritis. | lld:pubmed |
| pubmed-article:8702446 | pubmed:affiliation | Royal Postgraduate Medical School, Hammersmith Hospital, London, UK. | lld:pubmed |
| pubmed-article:8702446 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:8702446 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:8702446 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8702446 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8702446 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8702446 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8702446 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8702446 | lld:pubmed |
